Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis.
Pfizer Inc. (NYSE: PFE) on Tuesday gave a first glimpse of its fiscal 2026 guidance. The U.S. pharma giant sees 2026 adjusted earnings of $2.80-$3.00 per share compared to the consensus of $3.06.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback